Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

RNA-seq of mouse EO771 triple-negative breast cancer model with stemness inhibitors: salinomycin, SB-431542, JIB-04, napabucasin, and their quadruple combination against an untreated control


ABSTRACT: We conducted an in vivo study of stemness inhibitors using the EO771 triple-negative breast cancer mouse model. Ten days after subcutaneous injection of 1 million of EO771 cells into 8-12 week C57BL/6 female mice right flank, tumors reached around 100-200 mm³. Each treatment group (n=2-3 per group) received three doses of stemness inhibitors (every 3 days) in monotherapy (A - salinomycin, B - SB-431542, C - JIB-04, D - napabucasin) or combination therapy (ABCD). Control mice were left untreated. Tumors were harvested one day after the last treatment and subjected to bulk RNA-seq. This study aims to identify if treatment with stemness inhibitors affected the immune tumor microenvironment in this model.

INSTRUMENT(S): NextSeq 500

ORGANISM(S): Mus musculus

SUBMITTER:  

PROVIDER: E-MTAB-14915 | biostudies-arrayexpress |

SECONDARY ACCESSION(S): ERP170046

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2025-02-24 | E-MTAB-14870 | biostudies-arrayexpress
2023-06-30 | E-MTAB-12928 | biostudies-arrayexpress
2022-07-13 | E-MTAB-11939 | biostudies-arrayexpress
2019-02-18 | E-MTAB-7662 | biostudies-arrayexpress
2023-05-27 | E-MTAB-12776 | biostudies-arrayexpress
2021-02-04 | E-MTAB-9977 | biostudies-arrayexpress
2021-05-02 | E-MTAB-10381 | biostudies-arrayexpress
2022-09-16 | E-MTAB-9934 | biostudies-arrayexpress
2007-09-22 | E-GEOD-1872 | biostudies-arrayexpress
2019-11-01 | E-MTAB-8343 | biostudies-arrayexpress